NCT02641587View on ClinicalTrials.gov

Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting.

NACompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

July 31, 2017

Conditions
Smoking
Interventions
OTHER

CHTP 1.2

Ad libitum use of the CHTP 1.2 for 5 days in confinement followed by 85 days in an ambulatory setting.

OTHER

CC

Ad libitum use of subject's own preferred non-menthol brand of CC for 5 days in confinement followed by 85 days in an ambulatory setting.

Trial Locations (1)

05-830

BioVirtus Research Site Sp. z o.o., Nadarzyn

All Listed Sponsors
lead

Philip Morris Products S.A.

INDUSTRY

NCT02641587 - Reduced Exposure Study Using the CHTP 1.2 With 5 Days in a Confinement Setting Followed by 85 Days in an Ambulatory Setting. | Biotech Hunter | Biotech Hunter